Urogen Pharma shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Urogen Pharma
Tip: Access up to 7 years of quarterly data
All positions including Urogen Pharma held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Urogen Pharma by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $48M | 4.4M | 11.06 |
| 2024-12-31 | $15M | 1.4M | 10.65 |
| 2024-09-30 | $17M | 1.3M | 12.70 |
| 2024-06-30 | $22M | 1.3M | 16.78 |
| 2022-03-31 | $195k | 22k | 8.71 |
| 2021-12-31 | $213k | 22k | 9.51 |
| 2021-09-30 | $377k | 22k | 16.82 |
| 2021-06-30 | $342k | 22k | 15.27 |
| 2021-03-31 | $436k | 22k | 19.48 |
| 2020-12-31 | $432k | 22k | 19.29 |
| 2020-09-30 | $432k | 22k | 19.29 |
| 2020-06-30 | $499k | 19k | 26.12 |
| 2020-03-31 | $389k | 22k | 17.84 |
| 2019-12-31 | $547k | 16k | 33.37 |
| 2019-06-30 | $219k | 6.1k | 35.94 |
| 2019-03-31 | $225k | 6.1k | 36.94 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas